Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy

Código QR

Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy

Qianxing Mo et al. identify basal and luminal integrative subtypes of muscle-invasive bladder cancer (MIBC) using multi-omics data from The Cancer Genome Atlas. Using a gene panel for classification of MIBC derived from gene expression data, they find that the basal subtype is associated with worse...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Qianxing Mo, Roger Li, Dennis O. Adeegbe, Guang Peng, Keith Syson Chan
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/a3134628a64a497aa1f965d32da0006c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
por: Ann Taber, et al.
Publicado: (2020)

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
por: Sia Viborg Lindskrog, et al.
Publicado: (2021)

An N-Cadherin 2 expressing epithelial cell subpopulation predicts response to surgery, chemotherapy and immunotherapy in bladder cancer
por: Kenneth H. Gouin, et al.
Publicado: (2021)

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer
por: David Liu, et al.
Publicado: (2017)

Prognostic value of prostate volume in non-muscle invasive bladder cancer
por: Won Sik Ham, et al.
Publicado: (2021)

[2] Neoadjuvant intravesical chemotherapy to treat extended large non-muscle-invasive bladder cancer
por: Marco Raber, et al.
Publicado: (2018)

The Influence of Lymph Node Count on Oncological Outcome of Radical Cystectomy in Chemotherapy Pre-Treated and Chemotherapy-Naïve Patients with Muscle Invasive Bladder Cancer
por: Artur Lemiński, et al.
Publicado: (2021)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Zheng Liu, et al.
Publicado: (2021)

Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence
por: Zhipeng Xu, et al.
Publicado: (2021)

Prognostic value of preoperative neutrophil-to-lymphocyte ratio in histological variants of non-muscle-invasive bladder cancer
por: Deng-xiong Li, et al.
Publicado: (2021)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Xiaonan Zheng, et al.
Publicado: (2021)

Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
por: Shimpei Yamashita, et al.
Publicado: (2020)

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain
por: Ana Plata, et al.
Publicado: (2021)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Yinqi Zhang, et al.
Publicado: (2021)

Differential gene expression profile between progressive and de novo muscle invasive bladder cancer and its prognostic implication
por: Raquel Carrasco, et al.
Publicado: (2021)

Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma
por: Shuxiong Zeng, et al.
Publicado: (2017)

Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
por: Xiaoqi Sun, et al.
Publicado: (2021)

The Effect of Tri-Modality Therapy with Bladder Preservation for Selective Muscle-Invasive Bladder Cancer
por: Zhang Zhiyu, et al.
Publicado: (2021)

A review on the evolution of immunotherapy in bladder carcinoma
por: Milena Gulinac, et al.
Publicado: (2020)

Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non–muscle-invasive bladder cancer patients
por: Bum Sik Tae, et al.
Publicado: (2017)

(Pro)renin Receptor Is a Novel Independent Prognostic Marker in Invasive Urothelial Carcinoma of the Bladder
por: Gorka Larrinaga, et al.
Publicado: (2021)

On the protest frontline
por: Joseph Morokana
Publicado: (1997)

Frontline gastroenterology
Publicado: (2010)

Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy.
por: Margot Geens, et al.
Publicado: (2021)

NON-INVASIVE TREATMENT OF MUSCLE INVASIVE BLADDER CANCER IN PATIENTS WITH DERANGED RENAL PROFILE
por: Muhammad Adnan Zeb, et al.
Publicado: (2018)

Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Ying Jing, et al.
Publicado: (2020)

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab
por: Neel I. Nissen, et al.
Publicado: (2021)

Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder Cancer
por: Chengcheng Wei, et al.
Publicado: (2021)

[53] Neutrophil-to-lymphocyte ratio in non-muscle-invasive bladder cancer
por: Anés Sempere, et al.
Publicado: (2018)

Single-Cell Proteomic Analysis Dissects the Complexity of Tumor Microenvironment in Muscle Invasive Bladder Cancer
por: Chao Feng, et al.
Publicado: (2021)

S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
por: Yuan Chen, et al.
Publicado: (2021)

Prognostic Effect of Preoperative Psoas Muscle Hounsfield Unit at Radical Cystectomy for Bladder Cancer
por: Yusuke Sugino, et al.
Publicado: (2021)

Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: David J. Benjamin, et al.
Publicado: (2021)

Inflammatory Markers and Thromboembolic Risk in Patients with Non-Muscle-Invasive Bladder Cancer
por: Daniel Balan, et al.
Publicado: (2021)

Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice
por: Smilowitz HM, et al.
Publicado: (2017)

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Mi Ah Han, et al.
Publicado: (2021)

Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas
por: Wentao Fang, et al.
Publicado: (2021)

Prognostic relevance of urinary bladder cancer susceptibility loci.
por: Anne J Grotenhuis, et al.
Publicado: (2014)

Association Of Plasma And Urinary Mutant DNA With Clinical Outcomes In Muscle Invasive Bladder Cancer
por: K. M. Patel, et al.
Publicado: (2017)

Novel emerging biomarkers to immunotherapy in kidney cancer
por: Yasser Ged, et al.
Publicado: (2021)